Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the release of its new, highly sensitive and specific T7 RNA Polymerase ELISA Kits for the detection and quantitative determination of T7 RNA Polymerase in biopharmaceutical samples. These kits provide a critical tool for researchers and manufacturers to monitor and control...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced its comprehensive suite of services for Influenza Antiviral Drug Screening and Evaluation. Equipped with advanced technology platforms and a wide range of cell and animal models, the company now offers robust solutions to accelerate the discovery and development of novel...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the expansion of its Hepatitis B research portfolio with a comprehensive range of sensitive and specific Hepatitis B Virus Surface Antigen L-proteins. These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical development. These new services will support...

Creative Diagnostics, a leading provider of reagents and analytical services for biological studies, has released RNA Detection Assay Kits (qPCR) for quantifying RNA molecules. For scholars and researchers specializing in RNA molecules, these kits become effective tools that are useful in promoting the development of molecular biology studies. qPCR is a PCR-based technique and it has the...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. These antibodies have been meticulously validated for use in ELISA, LFIA, CLIA, and Western blot. With excellent specificity and sensitivity, these products are reliable tools for...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced its comprehensive suite of Vaccine Evaluation Services to support researchers and pharmaceutical companies in the critical early stages of antiviral vaccine evaluation and development. These laboratory services provide guidance for early vaccine detection, ensure compliance with...

Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Insect Nucleic Acid Residue Assay Kits based on quantitative fluorescence PCR technology. These kits are designed for highly sensitive and specific detection of insect DNA residues, ensuring the quality and safety of biopharmaceuticals, research products, and other...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is pleased to announce availability of its MERS-CoV Animal Models to support antiviral research. These animal models are valuable tools to advance research into the complex pathogenesis of MERS-CoV, evaluate potential therapeutic interventions and accelerate the development of effective...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its new Ovalbumin Epitope Peptide Antibodies for immunological research by enabling precise and efficient analysis of immune responses. These antibodies can be applied in immunology, allergy, and vaccine development research. Ovalbumin (OVA), a common allergen found in egg...